Latest news
Solventum Corporation (NYSE:SOLV) Receives Consensus Rating of "Hold" from Brokerages - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:17:04 GMTSOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook - TradingViewTradingView · Fri, 07 Aug 2026 21:50:50 GMTSolventum to Spin Off Health IT Unit After 3M Split - Medical Device and Diagnostic industryMedical Device and Diagnostic industry · Thu, 06 Aug 2026 19:45:29 GMTSolventum (NYSE:SOLV) Given New $105.00 Price Target at Piper Sandler - MarketBeatMarketBeat · Thu, 06 Aug 2026 18:16:29 GMTWedbush Raises Solventum (NYSE:SOLV) Price Target to $101.00 - MarketBeatMarketBeat · Thu, 06 Aug 2026 16:13:41 GMTSolventum (NYSE:SOLV) Reaches New 1-Year High on Earnings Beat - MarketBeatMarketBeat · Thu, 06 Aug 2026 14:45:34 GMTWhat Solventum (SOLV)'s Earnings Beat And Health IT Spinoff Plan Means For Shareholders - simplywall.stsimplywall.st · Thu, 06 Aug 2026 07:40:40 GMTSolventum (SOLV) Q2 2026 Earnings Call Transcript - FortuneFortune · Thu, 06 Aug 2026 03:30:00 GMT